BRPI0810092A2 - Oxazolidinonas para o tratamento e profilaxia de hipertensão pulmonar - Google Patents

Oxazolidinonas para o tratamento e profilaxia de hipertensão pulmonar

Info

Publication number
BRPI0810092A2
BRPI0810092A2 BRPI0810092-6A2A BRPI0810092A BRPI0810092A2 BR PI0810092 A2 BRPI0810092 A2 BR PI0810092A2 BR PI0810092 A BRPI0810092 A BR PI0810092A BR PI0810092 A2 BRPI0810092 A2 BR PI0810092A2
Authority
BR
Brazil
Prior art keywords
oxazolidinones
prophylaxis
treatment
lung hypertension
hypertension
Prior art date
Application number
BRPI0810092-6A2A
Other languages
English (en)
Inventor
Georges Von Degenfeld
Martina Klein
Elisabeth Perzborn
Joachim Huetter
Gerrit Weimann
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of BRPI0810092A2 publication Critical patent/BRPI0810092A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/421—1,3-Oxazoles, e.g. pemoline, trimethadione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Virology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Pulmonology (AREA)
  • AIDS & HIV (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
BRPI0810092-6A2A 2007-04-20 2008-04-10 Oxazolidinonas para o tratamento e profilaxia de hipertensão pulmonar BRPI0810092A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102007018662A DE102007018662A1 (de) 2007-04-20 2007-04-20 Oxazolidinone zur Behandlung und Prophylaxe von pulmonaler Hypertonie
PCT/EP2008/002829 WO2008128653A1 (de) 2007-04-20 2008-04-10 Oxazolidinone zur behandlung und prophylaxe von pulmonaler hypertonie

Publications (1)

Publication Number Publication Date
BRPI0810092A2 true BRPI0810092A2 (pt) 2014-10-14

Family

ID=39683728

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0810092-6A2A BRPI0810092A2 (pt) 2007-04-20 2008-04-10 Oxazolidinonas para o tratamento e profilaxia de hipertensão pulmonar

Country Status (13)

Country Link
US (1) US20100144728A1 (pt)
EP (1) EP2148672A1 (pt)
JP (1) JP2010524871A (pt)
KR (1) KR20100015675A (pt)
CN (1) CN101711155A (pt)
AU (1) AU2008241097A1 (pt)
BR (1) BRPI0810092A2 (pt)
CA (1) CA2684356A1 (pt)
DE (1) DE102007018662A1 (pt)
IL (1) IL201389A0 (pt)
MX (1) MX2009010861A (pt)
RU (1) RU2009142559A (pt)
WO (1) WO2008128653A1 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7816355B1 (en) 2009-04-28 2010-10-19 Apotex Pharmachem Inc Processes for the preparation of rivaroxaban and intermediates thereof

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0610265B1 (en) 1991-11-01 1996-12-27 PHARMACIA & UPJOHN COMPANY Substituted aryl- and heteroarylphenyloxazolidinones useful as antibacterial agents
SK283420B6 (sk) 1992-05-08 2003-07-01 Pharmacia & Upjohn Company Antimikrobiálne oxazolidinóny obsahujúce substituované diazínové skupiny
ATE181735T1 (de) * 1993-05-01 1999-07-15 Merck Patent Gmbh Substituierte 1-phenyl-oxazolidin-2-on derivate, deren herstellung und deren verwendung als adhäsionsrezeptor-antagonisten
DE19524765A1 (de) 1995-07-07 1997-01-09 Boehringer Mannheim Gmbh Neue Oxazolidinonderivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
PT1019385E (pt) 1995-09-15 2004-06-30 Upjohn Co N-oxidos de aminoaril-oxazolidinona
GB9614238D0 (en) 1996-07-06 1996-09-04 Zeneca Ltd Chemical compounds
DE19755268A1 (de) 1997-12-12 1999-06-17 Merck Patent Gmbh Benzamidinderivate
DE19962924A1 (de) 1999-12-24 2001-07-05 Bayer Ag Substituierte Oxazolidinone und ihre Verwendung
US20090075949A1 (en) 2004-10-25 2009-03-19 Wolfgang Eisert Use of dipyridamole in combination with antithrombotics for treatment and prevention of thromboembolic diseases
DE102005048824A1 (de) * 2005-10-10 2007-04-12 Bayer Healthcare Ag Behandlung und Prophylaxe von Mikroangiopathien

Also Published As

Publication number Publication date
US20100144728A1 (en) 2010-06-10
IL201389A0 (en) 2010-05-31
AU2008241097A1 (en) 2008-10-30
MX2009010861A (es) 2009-10-30
CN101711155A (zh) 2010-05-19
JP2010524871A (ja) 2010-07-22
RU2009142559A (ru) 2011-05-27
KR20100015675A (ko) 2010-02-12
WO2008128653A1 (de) 2008-10-30
CA2684356A1 (en) 2008-10-30
DE102007018662A1 (de) 2008-10-23
EP2148672A1 (de) 2010-02-03

Similar Documents

Publication Publication Date Title
BRPI0817096A2 (pt) análogos de tiazolidinodiona para o tratamento de hipertensão
CY2016017I1 (el) Συνθεση για θεραπεια πνευμονικης υπερτασης
CY2017024I1 (el) Παραγωγα αζετιδινης και κυκλοβουτανιου ως αναστολεις των jak
CY2018004I2 (el) Συνδυαστικη θεραπεια υποκατεστημενης oξαζολιδινονης
BRPI0814105A2 (pt) Métodos e composições para o tratamento de hipertensão pulmonar e doenças e distúrbios relacionados
CY2014026I2 (el) Συνθεσεις και χρησεις για θεραπεια σκληρυνσης κατα πλακας
BRPI0916862A2 (pt) compostos úteis para o tratamento de doenças degenerativas e inflamatórias
BRPI0921321A2 (pt) métodos para o tratamento de indwcções e tumores
DK2982696T3 (da) Behandling af akut lymfoblastær leukæmi
BRPI0810082A2 (pt) 3-imidazolil-indóis para o tratamento de doenças proliferativas
CR10932A (es) Delivery of ethylene blocking and/or promoting agents
ATE531720T1 (de) Aza-benzofuranylverbindungen und anwendungsverfahren dafür
CR9878A (es) Tratamiento y profilaxis de microangiopatias
BRPI0919804A2 (pt) Métodos e composição para o tratemento de problemas dermatológicos e/ou condições de cabelo
ATE526567T1 (de) Zusammensteller und zusammenstellungsverfahren
BRPI1014759A2 (pt) composto útil para o tratamento de doenças degenerativas e inflamatórias
BRPI0909460A2 (pt) Composições e métodos para controlar patógenos fúngicos de oomicete
DE602007004689D1 (de) Persönlicher Domänen-Controller
BRPI0718548A2 (pt) Estabilização de vacinas por liofilização
BRPI0919150A2 (pt) aplicadores de fluxo de ar e métodos de tratamento relacionados
BRPI0907954A2 (pt) Tratamento de hipertensão com 25-hidroxivitamina d3
BRPI0819105A2 (pt) composição para o tratamento e prevenção de edema de pálpebra
DOP2010000373A (es) Derivados de urea heterociclicos para el tratamiento de infecciones bacterianas
BR112012003209A2 (pt) composições e métodos para tratar infecção fúngica da unha
BRPI0914454A2 (pt) "composição para o tratamento do tecido epitelial"

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 5A, 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2329 DE 25-08-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

B350 Update of information on the portal [chapter 15.35 patent gazette]